{"article_title": "Biogen Has a Cure for Biotech Blues", "article_keywords": ["real", "biotech", "stocks", "trounced", "percentage", "shares", "past", "yearsof", "cure", "stock", "blues", "schmapplethe", "biogen", "points"], "article_url": "http://www.wsj.com/articles/biogen-has-a-cure-for-biotech-blues-1437674964", "article_text": "Apple, schmapple.\n\nThe real action in the stock market these days has been in biotechnology stocks such as Biogen Inc. Its shares have trounced those of the iPhone maker by 600 percentage points in the past three years.\n\nOf course, investors in most other industries don\u2019t have to deal with binary outcomes in the event of failure. Microsoft...", "article_metadata": {"article.template": "snippet", "article.created": "2015-07-23T18:09:00.000Z", "article.section": "Markets", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Jitters about Biogen\u2019s current and future products may produce a rare buying opportunity in a hot sector.", "creator": "@spencerjakab", "image": {"src": "https://si.wsj.net/public/resources/images/BN-JN379_0723ta_G_20150723115602.jpg", "alt": "Biogen has a cure for biotech blues", "identifier": "https://si.wsj.net/public/resources/images/BN-JN379_0723ta_D_20150723115602.jpg"}, "title": "Biogen Has a Cure for Biotech Blues", "site": "@WSJ", "card": "summary_large_image"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10748754293200604175404581126411883431364&headline=Biogen%20has%20a%20cure%20for%20biotech%20blues&weburl=http://www.wsj.com/articles/SB10748754293200604175404581126411883431364"}}, "page.site.product": "WSJ", "keywords": "alzheimer's drugs,apple,biib037,biogen,biotech,hot stocks,Biogen,BIIB,Microsoft,MSFT,Pfizer,PFE,Ford Motor,F,Apple,AAPL,biotechnology,political,general news,sciences,technologies,pharmaceuticals,health care,life sciences,biopharmaceuticals", "news_keywords": "alzheimer's drugs,apple,biib037,biogen,biotech,hot stocks,Biogen,BIIB,Microsoft,MSFT", "article.headline": "Biogen has a cure for biotech blues", "cXenseParse": {"candybar": {"image": "https://si.wsj.net/public/resources/images/BN-JN379_0723ta_E_20150723115602.jpg"}, "poptart": {"image": "https://si.wsj.net/public/resources/images/BN-JN379_0723ta_D_20150723115602.jpg"}}, "description": "Jitters about Biogen\u2019s current and future products may produce a rare buying opportunity in a hot sector.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10748754293200604175404581126411883431364&headline=Biogen%20has%20a%20cure%20for%20biotech%20blues&weburl=http://www.wsj.com/articles/SB10748754293200604175404581126411883431364", "user.type": "nonsubscriber", "article.page": "Stocks", "page.content.format": "responsive", "article.summary": "Jitters about Biogen\u2019s current and future products may produce a rare buying opportunity in a hot sector.", "page.site": "wsj", "testkeys": "B", "article.published": "2015-07-23T18:09:00.000Z", "dj.asn": "i-f261", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"internal_link_count": 2, "publisher": "https://www.facebook.com/wsj", "image_count": 2, "word_count": 377, "external_link_count": 1}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Jitters about Biogen\u2019s current and future products may produce a rare buying opportunity in a hot sector.", "title": "Biogen Has a Cure for Biotech Blues", "url": "http://www.wsj.com/articles/biogen-has-a-cure-for-biotech-blues-1437674964", "image": {"width": 553, "identifier": "https://si.wsj.net/public/resources/images/BN-JN379_0723ta_G_20150723115602.jpg", "height": 369}, "locale": "en_US", "type": "article"}, "author": "Spencer Jakab", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Biogen Has a Cure for Biotech Blues", "article.type": "Ahead of the Tape", "article.id": "SB10748754293200604175404581126411883431364", "user.exp": "default", "article.updated": "2015-07-23T18:09:00.000Z"}, "_id": "\"57477af36914bd0286fcc589\"", "article_summary": "The real action in the stock market these days has been in biotechnology stocks such as Biogen Inc. Its shares have trounced those of the iPhone maker by 600 percentage points in the past three years.\nOf course, investors in most other industries don\u2019t have to deal with binary outcomes in the event of failure.\nApple, schmapple.\nMicrosoft..."}